Exercise extreme caution in Remdesivir use: Centre

In revised advisory, Health Ministry says it is not suggested for patients with mild symptoms

The Health Ministry said on Monday that Remdesivir, a drug currently used in treatment of COVID-19, can be used only in select moderate/ severe hospitalised patients on supplemental oxygen, as it is a reserve drug approved under the Emergency Use Authorization based on limited scientific evidence globally. In a revised advisory, it said the drug is not indicated in patients with mild symptoms who are in home care/ COVID Care Centres and that doctors are advised to exercise extreme caution in using this reserve/ experimental/ emergency use authorisation drug. The Ministry said the advisory is aimed at stopping the misuse of this experimental drug, which is relatively expensive, has limited availability and has a potential to harm. To stop the misuse of the drug, the Ministry has recommended that Remdesivir must be advised by senior faculty members/ specialists directly involved in a patient’s care.